CN109310669B - 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 - Google Patents

氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 Download PDF

Info

Publication number
CN109310669B
CN109310669B CN201780030912.5A CN201780030912A CN109310669B CN 109310669 B CN109310669 B CN 109310669B CN 201780030912 A CN201780030912 A CN 201780030912A CN 109310669 B CN109310669 B CN 109310669B
Authority
CN
China
Prior art keywords
trigeminal
trigeminal neuralgia
use according
painful
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780030912.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN109310669A (zh
Inventor
曹民宰
黄善宽
李翰柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Biopharmaceuticals Co Ltd
Original Assignee
SK Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Biopharmaceuticals Co Ltd filed Critical SK Biopharmaceuticals Co Ltd
Publication of CN109310669A publication Critical patent/CN109310669A/zh
Application granted granted Critical
Publication of CN109310669B publication Critical patent/CN109310669B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201780030912.5A 2016-05-19 2017-05-18 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 Active CN109310669B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0061386 2016-05-19
KR20160061386 2016-05-19
PCT/KR2017/005172 WO2017200317A1 (ko) 2016-05-19 2017-05-18 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (2)

Publication Number Publication Date
CN109310669A CN109310669A (zh) 2019-02-05
CN109310669B true CN109310669B (zh) 2022-02-22

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780030912.5A Active CN109310669B (zh) 2016-05-19 2017-05-18 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途

Country Status (14)

Country Link
US (1) US11207295B2 (https=)
EP (1) EP3459542B1 (https=)
JP (1) JP6960415B2 (https=)
KR (1) KR102421013B1 (https=)
CN (1) CN109310669B (https=)
AU (1) AU2017267160B2 (https=)
CA (1) CA3024284C (https=)
DK (1) DK3459542T3 (https=)
ES (1) ES2887338T3 (https=)
MX (1) MX389613B (https=)
PL (1) PL3459542T3 (https=)
PT (1) PT3459542T (https=)
RU (1) RU2751504C2 (https=)
WO (1) WO2017200317A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556365B1 (en) * 2016-12-14 2025-07-02 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
ES2978226T3 (es) * 2018-09-21 2024-09-09 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
AU2019361856B2 (en) * 2018-10-19 2024-11-07 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101228138A (zh) * 2005-04-22 2008-07-23 Sk株式会社 神经治疗吡咯化合物
CN102574821A (zh) * 2009-10-15 2012-07-11 爱思开生物制药株式会社 制备氨基甲酸(r)-1-芳基-2-四唑基-乙酯的方法
CN102803233A (zh) * 2009-06-22 2012-11-28 爱思开生物制药株式会社 制备氨基甲酸(r)-1-芳基-2-四唑基-乙酯的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
IL157593A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
JP4227121B2 (ja) 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
CA2817290A1 (en) * 2010-11-11 2012-05-18 Josef Penninger Compounds and methods for treating pain
MX368735B (es) 2014-05-09 2019-10-14 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101228138A (zh) * 2005-04-22 2008-07-23 Sk株式会社 神经治疗吡咯化合物
CN102803233A (zh) * 2009-06-22 2012-11-28 爱思开生物制药株式会社 制备氨基甲酸(r)-1-芳基-2-四唑基-乙酯的方法
CN102574821A (zh) * 2009-10-15 2012-07-11 爱思开生物制药株式会社 制备氨基甲酸(r)-1-芳基-2-四唑基-乙酯的方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development;Gaetano Zaccara等;《Pharmacological Research》;20151212;第104卷;第38-48页 *
Meir Bialer等.Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X).《Epilepsy Research》.2010,第92卷第89-124页. *
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X);Meir Bialer等;《Epilepsy Research》;20101201;第92卷;第89-124页 *
加巴喷丁与卡马西平治疗三叉神经痛的对比分析;陈忠红;《中国卫生标准管理》;20150721;第15卷;第133-134页 *

Also Published As

Publication number Publication date
WO2017200317A1 (ko) 2017-11-23
RU2751504C2 (ru) 2021-07-14
KR102421013B1 (ko) 2022-07-14
EP3459542A4 (en) 2020-01-08
KR20170131241A (ko) 2017-11-29
US11207295B2 (en) 2021-12-28
JP6960415B2 (ja) 2021-11-05
PL3459542T3 (pl) 2021-12-27
AU2017267160A1 (en) 2018-12-13
AU2017267160B2 (en) 2022-11-10
RU2018144784A (ru) 2020-06-19
PT3459542T (pt) 2021-08-24
MX2018014081A (es) 2019-09-02
US20190175555A1 (en) 2019-06-13
CA3024284A1 (en) 2017-11-23
US20220087976A1 (en) 2022-03-24
DK3459542T3 (da) 2021-09-13
EP3459542B1 (en) 2021-06-30
RU2018144784A3 (https=) 2020-08-11
ES2887338T3 (es) 2021-12-22
CA3024284C (en) 2024-01-23
JP2019516722A (ja) 2019-06-20
MX389613B (es) 2025-03-20
EP3459542A1 (en) 2019-03-27
BR112018073556A2 (pt) 2019-03-19
CN109310669A (zh) 2019-02-05

Similar Documents

Publication Publication Date Title
JP6257326B2 (ja) 神経因性疼痛におけるマロノニトリルアミドの使用
JP5921539B2 (ja) 下肢静止不能症候群を治療する方法
ES2743153T3 (es) Métodos para tratar el síndrome de fibromialgia
JP7071287B2 (ja) 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用
CN109310669B (zh) 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途
US11571410B2 (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
JP7417595B2 (ja) てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用
US12611395B2 (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
EP3711757B1 (en) Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
KR20210062029A (ko) 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도
HK40003859A (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
HK40003859B (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
BR112018073556B1 (pt) Uso de um composto de carbamato
HK40015213A (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
HK40005640B (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
HK40005640A (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40003859

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant